Cargando…
Antigen Concentrations as an Indicator of Clinical Remission and Disease Relapse in Cats with Histoplasmosis
BACKGROUND: Treatment monitoring is subjective and disease relapse is common in cats with histoplasmosis. The Histoplasma antigen enzyme immunoassay (EIA) is a noninvasive test used for determining disease remission and detecting disease relapse in humans with histoplasmosis. The utility of the anti...
Autores principales: | Hanzlicek, A.S., Meinkoth, J.H., Renschler, J.S., Goad, C., Wheat, L.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084835/ https://www.ncbi.nlm.nih.gov/pubmed/27158815 http://dx.doi.org/10.1111/jvim.13962 |
Ejemplares similares
-
A monoclonal antibody‐based urine Histoplasma antigen enzyme immunoassay (IMMY®) for the diagnosis of histoplasmosis in cats
por: Rothenburg, Lana, et al.
Publicado: (2018) -
Clinical utility of fungal culture and antifungal susceptibility in cats and dogs with histoplasmosis
por: Hanzlicek, Andrew S., et al.
Publicado: (2023) -
Evaluation of an enzyme immunoassay and immunodiffusion for detection of anti‐Histoplasma
antibodies in serum from cats and dogs
por: Tims, Rebecca, et al.
Publicado: (2023) -
Reduced susceptibility to fluconazole in a cat with histoplasmosis
por: Renschler, Janelle S, et al.
Publicado: (2017) -
Evaluation of serum 25‐hydroxyvitamin D, C‐reactive protein, and haptoglobin as biomarkers in dogs newly diagnosed with histoplasmosis
por: Hernandez, Betsy, et al.
Publicado: (2023)